VAUGHAN, Ontario–(BUSINESS WIRE)–LGC Group, a global leader in life sciences, today officially opened its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD$100 million investment. The 203,000 ft² (17,200 m²) facility is one of the largest of its kind in the world. It reinforces Canada’s role as a hub for global scientific innovation and manufacturing, while significantly expanding TRC’s capacity to serve pharmaceutical, biotechnology, and life sciences customers worldwide.
The new facility expands the capabilities of Toronto Research Chemicals (TRC), an organization founded at the University of Toronto more than 40 years ago and acquired by LGC Group in 2019. TRC is internationally recognized for its expertise in synthesizing complex organic molecules, many of which are only available from TRC. These molecules underpin drug discovery pipelines, forensic testing, food and environmental safety, and industrial innovation, giving customers reliable access to critical building blocks for science.
A world-class investment in Canadian science and expertise
Canada’s growing knowledge economy is strengthened by strong government support, including $1.3B in new federal funding announced in July 2025 to advance researchers and their projects. Ontario, as a province that is “Open for Business,” provides a thriving environment for innovation, with policies that encourage investment and enable collaboration between academia, industry, and enterprise.
“This investment reflects our confidence in Ontario and Canada as a centre of scientific talent and innovation,” said Joydeep Goswami, CEO of LGC Group. “From Vaughan, our scientists supply the world with critical tools that enable breakthroughs in drug discovery, public health, food safety, and environmental protection.”
Global reach, local impact
Products manufactured in Vaughan are shipped to more than 170 countries, supporting research in areas such as cancer, infectious disease, mental health, and environmental safety. For customers, the expanded facility means greater reliability, scale, and speed of delivery.
“TRC has been part of the Toronto science community for over four decades. With this new facility, we’re building on that legacy by creating an environment where scientists can collaborate, innovate, and make a difference on a global scale,” said Bruno Rossi, EVP and General Manager, LGC Standards.
Event highlights
To mark the grand opening, LGC hosted an inauguration ceremony featuring scientific leaders, government representatives, and global partners. The event also included a symposium on PFAS (per- and polyfluoroalkyl substances), widely known as “forever chemicals” because they persist in the environment and accumulate in people and wildlife. Linked to risks for human health and ecosystems, PFAS represent one of today’s most urgent environmental challenges. Bringing together experts from academia and industry to explore solutions, the symposium also underscored LGC’s leadership in this space, with one of the world’s broadest portfolios of reference standards to support PFAS detection, monitoring, and regulation worldwide.
Quotes
“In line with the priorities and ambitions outlined in our government’s Life Sciences Strategy, the new Organic Chemistry Synthesis Centre of Excellence will increase Ontario’s capacity to provide researchers around the world with indispensable organic molecules, strengthening the province’s position as a global hub for life sciences innovation. Our government is proud to see LGC Group deepen its investment in Toronto Research Chemicals (TRC), an Ontario organization that reflects the academic excellence and talent our province and its universities offer, and we thank them for choosing Ontario as a continued partner in their success.”
– Hon. Vic Fedeli, Minister of Economic Development, Job Creation and Trade
“Vaughan is a world-class destination for excellence in healthcare and health innovation. That’s why I am pleased that LGC-TRC has officially opened the Organic Chemistry Synthesis Centre of Excellence right here in Vaughan. The use of ‘excellence’ in its name says it all. This new state-of-the-art facility is designed to foster cutting-edge science and research, which will also create jobs and bring more top talent to our great city. Vaughan continues to be a destination of choice for business investment. I would like to extend my sincerest congratulations to LGC-TRC on this incredible achievement. Together, with our industry leaders, we’re building top-tier facilities and opportunities to advance healthcare delivery.”
– Mayor Steven Del Duca, City of Vaughan
“The opening of the Organic Chemistry Synthesis Centre of Excellence marks an important step forward in Ontario’s leadership in life sciences innovation and economic growth. Our government is excited to see LGC Group expand this province’s position on the global stage through a $100 million investment that aligns with Ontario’s Life Sciences Strategy. This centre will continue to drive global innovation, creating new opportunities for scientific breakthroughs, expanding our advanced manufacturing capacity, and building a stronger economy for the people of Ontario.”
– Brian Saunderson, MPP, Parliamentary Assistant to the Minister of Economic Development, Job Creation and Trade
“Ontario continues to demonstrate to the world that we are a premier destination for life sciences innovation, talent, and investment. LGC Group’s $100 million Centre of Excellence in Vaughan is a powerful example of how global leaders are choosing Ontario to expand their footprint, collaborate with our research community, and create new opportunities for our economy. This investment not only strengthens our position in the global life sciences ecosystem but also underscores the impact of Ontario-made innovation on advancing human health and wellbeing worldwide.”
– Claudia Krywiak, President and CEO of the Ontario Centre of Innovation (OCI)
“LGC’s $100 million investment in a new Organic Chemistry Synthesis Centre of Excellence in Vaughan marks a major milestone for Ontario’s life sciences sector. By expanding TRC’s world-class capacity, this facility strengthens Ontario’s position as a global hub of scientific innovation and manufacturing. Providing the capability to synthesize complex molecules, this scalable infrastructure will harness our scientific talent and accelerate discovery to provide solutions with global impact.”
– Dr. Jason Field, CEO & President, Life Sciences Ontario
“I am honoured to be a part of LGC-TRC’s Organic Chemistry Synthesis Centre of Excellence grand opening. In Vaughan, we welcome new businesses and ventures, and we’re always there to support them with the tools and resources they need to succeed – especially those that have a positive impact on the healthcare system. Congratulations to the entire LGC-TRC team on this new facility. Thank you for choosing Vaughan to be your new home for scientific excellence and innovation.”
– Councillor Adriano Volpentesta, City of Vaughan – Ward 2
About LGC
LGC is a global leader in life sciences, diagnostics, and analytical solutions. The company partners with customers to solve some of the world’s most pressing challenges. Every day, its science helps to diagnose disease, treat illness, feed a growing population, and protect public health. LGC provides the components, standards, and services that underpin scientific discovery, enable better health outcomes, and safeguard the integrity of food, water, medicines, and the environment.
With operations in 14 countries and a heritage of over 180 years, LGC’s products and services are integral to public health and global sustainability. From supporting the accuracy of medical test results to verifying the safety of baby food, to helping scientists develop the next generation of medicines, LGC’s solutions are trusted by customers in more than 170 countries.
About TRC:
Toronto Research Chemicals (TRC), part of LGC Standards, is recognised globally as a Centre of Excellence in organic chemistry synthesis. Founded at the University of Toronto more than 40 years ago, TRC now supplies a catalogue of over 100,000 research chemicals to scientists and manufacturers worldwide, advancing discoveries in pharmaceuticals, forensic science, food safety, and environmental analysis.
Contacts
For further information, please contact:
Magda Bartoszewicz
Director Corporate Brand and Communications
LGC Group
[email protected] | +44 7522 141 822
For additional media availability and event support, please contact:
Matthew Segal
Director, Communications
StrategyCorp, Inc.
[email protected] | 416-864-7914
